top of page
  • Writer's pictureDamon Butcher

Life Sciences Innovation Manufacturing Fund

Updated: Apr 22, 2022



This fund is to support businesses investing in life sciences manufacturing projects in the UK.

Open date: 07/03/2022

Close date: 31/03/2022

Max Funding: Share of £60m

Collaboration: Single

Funding Type: Innovation Grant

Fund Provider(s): Office for Life Sciences, Department for Business, Energy & Industrial Strategy

Industries: Life Sciences


Scheme Overview

The Department for Business, Energy and Industrial Strategy (BEIS) is launching the Life Sciences Innovative Manufacturing Fund (LSIMF) to support businesses investing in manufacturing projects in the UK. This £60m fund will provide capital grants for investments in the manufacture of human medicines (drug substance and drug product), medical diagnostics and MedTech products. This could include manufacturing investments in:

  • Curative and therapeutic treatments for both population-level and rare diseases (e.g., cell, gene, and nucleic acid therapies)

  • Earlier and better detection and diagnosis of disease (e.g., ‘breathalysers’ for the early detection of cancer or wearable continuous glucose monitors), or

  • Smarter pacemakers, tricorders and robotic surgical devices This list is not intended to be exhaustive

Scheme Objectives

BEIS aims to build a portfolio across high-quality projects, with Ministers making the final decision on which projects will receive funding. Applicants will be assessed and prioritised for funding based on their alignment to the fund’s objectives:

  • 1. Creating economic opportunity through investments that will make a substantial contribution to Gross Value Added and provide high-wage, high-skilled jobs;

  • 2. Deploying cutting-edge innovations (at either pilot or commercial scale) which may be embedded in the product itself or within the manufacturing process;

  • 3. Increasing health resilience in the UK through increased domestic capacity, or by providing flexible capabilities that have the ability to be re-deployed in a future health emergency;

  • 4. Minimising impact on the environment which might include becoming more sustainable through the reduction or use of alternative input resources (e.g. energy, solvents, water, carbon), the minimising of waste or supporting the Government’s Net Zero agenda


Inovasi helps companies to innovate with innovation incentives: R&D, Tax Credits, The Patent Box Scheme, and Funding. Inovasi aims to save you time, so you can focus on the core of your business, we offer expert advice, you can rest easy knowing your claim has been strictly adhered to HMRC legislation, reducing the chance of an inquiry, maximise all aspects of your innovation process, experienced, up to date on the latest guidance and changes related to grants.


bottom of page